Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank67
Studio
Year-over-Year Change

Return on equity

Percentile
P67
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024-26.41%+93.9%
2023-431.87%-213.2%
2022381.66%+204.4%
2021-365.55%-41.4%
2020-258.53%-237.7%
2019-76.55%+60.0%
2018-191.57%-549.6%
201742.61%+100.5%
2016-7957.00%-9824.6%
2015-80.17%-